A groundbreaking shift in Canadian drug policy has occurred, as the government permit the availability of psilocybin fungi for therapeutic treatment. Previously, these substances were severely restricted, but a mounting body of studies suggests they may offer aid for emotional conditions like PTSD. This development represents a substantial step tow